Gel formulations for treatment of the ophthalmic complications in cystinosis

B Buchan, G Kay, A Heneghan, KH Matthews… - International journal of …, 2010 - Elsevier
Nephropathic cystinosis is a rare autosomal recessive disease characterised by raised
lysosomal levels of cystine in the cells of all organs. It is treated by regular administration of …

[PDF][PDF] Reconstituted ocular gel for cystinosis treatment

M Santaniello, L Critelli, G Quattrociocchi… - Journal of drug …, 2011 - academia.edu
Cystinosis is a rare genetic disorder that causes an accumulation of cystine into cells and its
corneal crystal deposition. The main treatment for this ocular disorder remains the …

Three salts from the reactions of cysteamine and cystamine with L-(+)-tartaric acid

A Benylles, D Cairns, PJ Cox, G Kay - Acta crystallographica section …, 2013 - scripts.iucr.org
Reaction between cysteamine (systematic name: 2-aminoethanethiol, C2H7NS) and l-(+)-
tartaric acid [systematic name:(2R, 3R)-2, 3-dihydroxybutanedioic acid, C4H6O6] results in a …

The design and synthesis of novel pro-drugs for the treatment of nephropathic cystinosis.

A Bahmed - 2015 - rgu-repository.worktribe.com
Cystinosis is a metabolic disorder characterised by the abnormal accumulation of the amino
acid cystine in cells leading to a slow destruction of all major organs. If patients diagnosed …